Professor of Surgery Dmitry V. Garbuzenko, MD

---

Date of birth: 29 June 1962
The birthplace: village Pereyaslavka of Khabarovsky kray, Russia
Address: POBox 12317, Chelyabinsk, 454080, Russia
E-mail (1): garb@inbox.ru
E-mail (2): garbuzenkodv@gmail.com
Telegram/Viber/WhatsApp: +79097459826
Marital status: Married
Nationality: Russian
Education:

• 1979-1985: a student in Chelyabinsk State Medical Institute.
• 1985-1987: Post-graduate student, the Department of Hospital Surgery, Chelyabinsk State Medical Institute.
• 1987-1990: PhD student of the Department of Hospital Surgery, Chelyabinsk State Medical Institute.

Employment:

• 1991 - 2003: Assistant Professor of the Department of Faculty Surgery, Chelyabinsk State Medical Academy.
• 2003 - 2010: Associate Professor of the Department of Faculty Surgery, Chelyabinsk State Medical Academy.
• 2010 - to present: Professor of the Department of Faculty Surgery, South Ural State Medical University.

Academic title: Professor
Qualifications: Surgeon of the highest category
Work Experience: My practical activities are associated with emergency abdominal surgery. I am able to perform all kinds of operations on the abdominal organs and specialize in surgery of the liver, biliary tract, and pancreas. I have the extensive experience in experimental work on the problem of portal hypertension (modeling, treatment).

Skills: Microsoft Office (Word, Excel)
Languages: native speaker of Russian, working knowledge of English.

Scientific achievements:

• 1991: Defended a candidate’s dissertation (PhD) on subject: "Influence of a small bowel resection on the clinical course of portal hypertension".
• 2008: Defended a doctoral dissertation on subject: "The effect of the laser revascularization of the cirrhotic liver on portal hypertension".

h-index:

• Russian Science Citation Index - 21.
• Web of Science - 9.
• Scopus - 9.

Sphere of my Research Interests includes clinical and pathological problems associated with liver cirrhosis and portal hypertension.
I am the member of the Russian Society of Surgeons, the Russian Gastroenterological Association, the International Association of Surgeons-Hepatologists, the Russian Academy of Natural Sciences.
I am an author of more than 208 publications (some of them are listed below), 7 inventions, 3 monographs:

• Gastroesophageal variceal hemorrhage in cirrhotic patients: pathogenesis, prophylactic, treatment. - Chelyabinsk, Russia: "Eastern Gate", 2004 (in Russian).
• Selected lectures in emergency abdominal surgery. - Saarbrücken, Germany: LAP LAMBERT Academic Publishing GmbH& Co., 2012 (in Russian).
• Angiogenesis: The new aim for targeted therapy of portal hypertension for liver cirrhosis. - M.: Nauka, 2020 (in Russian).
  

Co-author of the monograph:

• Anti-Angiogenesis Drug Discovery and Development. Vol. 4. Ed. Atta-ur-Rahman and M. Iqbal Choudhary. - Sharjah, UAE: Bentham Science Publishers, 2019. - 228 p.

The editor of the books:

• Portal Hypertension - Causes and Complications. Ed. D. Garbuzenko. - Rijeka, Croatia: InTech, 2012. - 144 p.
• Actual Problems of Emergency Abdominal Surgery. Ed. D. Garbuzenko. - Rijeka, Croatia: InTech, 2016. - 208 p.
• Current Issues in the Diagnostics and Treatment of Acute Appendicitis. Ed. D. Garbuzenko. - London, United Kingdom: InTech, 2018. - 92 p.
• Pancreatitis. Ed. D. Garbuzenko. - London, United Kingdom: InTech, 2019. - 82 p.
• Intestinal Obstruction. Ed. D. Garbuzenko. - London, United Kingdom: InTech, 2020. - 82 p.
• Abdominal Trauma - New Solutions to Old Problems. Ed. D. Garbuzenko. - London, United Kingdom: InTech, 2023. - 112 p.
  

Co-author of the clinical guidelines: Treatment of liver cirrhosis complications: Clinical guidelines of the Russian Scientific Liver Society and Russian gastroenterological association.

Online Academic Editor of the Management Team of the Baishideng Publishing Group.

Editorial board member:

• World Journal of Hepatology ^CERTIFICATE (Associate Editor).
• International Journal of Medical and Health Research ^CERTIFICATE.  
  

Peer-reviewer:

• World Journal of Gastroenterology.
• World Journal of Clinical Cases.
• World Journal of Transplantation.
• Journal of Digestive Diseases.
• European Medical Journal Hepatology. 
• Journal of International Medical Research.
• American Journal of Case Reports.
• Therapeutics and Clinical Risk Management.
• Medical Science Monitor.
• Hepatoma Research.
• BMJ Case Reports
• Annals of Translational Medicine
  
• Journal of Clinical Pharmacy & Therapeutics.
• Gastroenterology: Medicine & Research.
• JSM Gastroenterology and Hepatology.
  

List of publications:
1. Garbuzenko D.V., Lyannoy K.V. [The effect of the small intestinal resection on the pressure in the portal venous system in experimental portal hypertension]. Klin. Khir. 1990; 71 (11): 24-27 (in Russian) (pdf) (PubMed)
2. Malyshev Yu.I., Red'kin G.A., Garbuzenko D.V. [Results of the small intestinal resection in patients with portal hypertension]. Klin. Khir. 1991; 72 (9): 12-15 (in Russian) (pdf) (PubMed)
3. Garbuzenko D.V. [Phlegmon of the hernial sac after surgery for diffuse fibrinous peritonitis]. Klin. Khir. 1993; 74 (6): 66-67 (in Russian) (pdf) (PubMed)
4. Garbuzenko D.V. [Hemodynamic disorder, conditionned by liver cirrhosis]. Klin. Med. (Mosk). 1996; 74 (2): 5-7 (in Russian) (pdf) (PubMed)
5. Garbuzenko D.V., Sen'kova N.N., Bordunovsky V.N. [Method cultivation and transplantation isolated hepatocytes in experiment acute hepatic failure]. Ann. hir. gepatol. 1998; (2) (Suppl): 151 (in Russian)
6. Garbuzenko D.V., Sen'kova N.N. [Intraperitoneal transplantation of microcarrier-attached isolated hepatocytes in experiment]. Ros. gastrojenterol. zh. 1998; (4): 170-171 (in Russian)
7. Garbuzenko D.V., Popov G.K. [Mechanisms of liver regeneration regulation]. Ros. zhurn. gastrojenterol., gepatol., koloproktol. 2001; 11 (1): 21-25 (in Russian) (pdf)
8. Garbuzenko D.V. [Pathogenesis of portal hypertension at liver cirrhosis]. Ros. zhurn. gastrojenterol., gepatol., koloproktol. 2002; 12 (5): 23-29 (in Russian) (pdf)
9. Garbuzenko D.V., Marysheva I.V. [Modification of portal blood flow after lazer revascularization cirrhotic liver]. Jeksperimental klinich. gastrojenterol. 2003; (5) (Suppl): 133 (in Russian)
10. Garbuzenko D.V. [Pharmacotherapy in portal hypertension]. Klin. Med. (Mosk).) 2004; 82 (3): 16-20 (in Russian) (pdf) (PubMed) 
11. Garbuzenko D.V. [Portal-hypertensive gastropathy]. Medical Journal of the Russian Federation. 2004; (4): 44-45 (in Russian) (pdf)
12. Garbuzenko D.V. [Prophylaxis of bleedings from varicose esophageal and stomach veins in liver cirrhosis patients ]. Ros. zhurn. gastrojenterol., gepatol., koloproktol. 2004; 14 (4): 8-13 (in Russian) (pdf)
13. Garbuzenko D.V. [Laser revascularization of the cirrhotic liver as a way of portal hypertension management] Ann. hir. gepatol. 2004; 9 (2) (Suppl): 216 (in Russian) (pdf)
14. Garbuzenko D.V. [Porto-pulmonary hypertension and hepatopulmonary syndrome in patients with hepatic cirrhosis]. Pul'monologija 2006; (1): 103-107 (in Russian) (pdf)
15. Garbuzenko D.V. [The treatment tactics in the bleeding gastric varices]. Ann. hir. gepatol. 2007; 12 (1): 96-102 (in Russian) (pdf)
16. Garbuzenko D.V. [Multiorgan hemodynamic disorder, conditionned by liver cirrhosis]. Ter. Arkh. 2007; 79 (2): 73-77 (in Russian) (pdf) (PubMed) 
17. Kovalenko V.L., Abramovskaya N.V., Garbuzenko D.V.  [Morphological characteristic compensatory and adaptation response in the cirrhotic liver after influence of highenergy lazer radiation]. Ural. med. zhurn. 2007; (12): 75-78 (in Russian) (pdf)
18. Garbuzenko D.V. [The role of intestinal microflora in the development of complications of hepatic cirrhosis-associated portal hypertension]. Klin Med (Mosk). 2007; 85 (8): 15-9 (in Russian) (pdf) (PubMed)
19. Garbuzenko D.V. [Mechanisms of compensation of structure and function of the liver at its damage and their practical significance]. Ros. zhurn. gastrojenterol., gepatol., koloproktol. 2008; 18 (6): 14-21 (in Russian) (pdf)
20. Danilova T.V., Garbuzenko D.V., Mikurov A.A. [Cases of enteropathy, accompanied by uncontrolled bleeding in patients with liver cirrhosis with portal hypertension (morphological study)]. Ros. zhurn. gastrojenterol., gepatol., koloproktol. 2009; 19 (5) (Suppl 34): 47-47 (in Russian) (pdf)
21. Garbuzenko D.V. [Experimental methods of portal hypertension studying]. Ros. zhurn. gastrojenterol., gepatol., koloproktol. 2010; 20 (2): 4-12 (in Russian) (pdf)
22. Garbuzenko D.V. [Pathophysiological mechanisms and new directions of therapy of portal hypertension at liver cirrhosis]. Klin. persp. gastrojen. gepatol. 2010; (6): 11-20 (in Russian) (pdf)
23. Mikurov A.A., Garbuzenko D.V. [The comparative analysis of level endotoxemia at patients of the liver cirrhosis with portal hypertension]. Fundamental'nye issledovanija 2011; (6): 126-128 (in Russian) (pdf)
24. Garbuzenko D.V., Mikurov A.A. [The role of endotoxemia in the development of the bleeding esophageal varices in patients with liver cirrhosis]. Medical Journal of the Russian Federation. 2011; (6): 47-49 (in Russian) (pdf)
25. Garbuzenko D., Mikurov A., Smirnov D. The Bacterial Endotoxins Levels in the Blood of Cirrhotic Patients as Predictor of the Risk of Esophageal Varices Bleeding. In: Portal Hypertension - Causes and Complications. Ed. D. Garbuzenko. Rijeka, Croatia: InTech, 2012 p. 85-92 (pdf)
26. Garbuzenko D.V. [Methods of risk prediction and monitoring of treatment response rate of bleedings from esophageal varices in patients with liver cirrhosis]. Ros. zhurn. gastrojenterol., gepatol., koloproktol. 2012; 22 (2): 36-44 (in Russian) (pdf)
27. Garbuzenko D.V., Mikurov A., Smirnov D. [Bacterial endotoxinemia and the risk of the bleeding esophageal varices in patients with liver cirrhosis]. Klin. Med. (Mosk). 2012; 90 (7): 48-51 (in Russian) (pdf) (PubMed)
28. Garbuzenko D.V. [The mechanisms of adaptation of the vascular bed to hemodynamic changes in portal hypertension]. Vestn. Ross. Akad. Med. Nauk.  2013; (1): 52-57 (in Russian) (pdf) (PubMed)
29. Garbuzenko D.V. [The risk factors of extrahepatic abdominal operations in patients with liver cirrhosis]. Khirurgiia (Mosk). 2013; (8): 86-92 (in Russian) (pdf) (PubMed)
30. Garbuzenko D.V. [Portal biliopathy]. Vrach 2014; (1): 17-20 (in Russian) (pdf)
31. Garbuzenko D.V. [Morphofunctional rearrangement of the hepatic vasculature in the pathogenesis of portal hypertension in liver cirrhosis]. Ter. Arkh. 2014; 86 (2): 90-95 (in Russian) (pdf) (PubMed)
32. Garbuzenko D.V. [Ectopic varicosis: a rare case of gastrointestinal hemorrhage]. Klin. Med. (Mosk). 2014; 92 (6): 12-21 (in Russian) (pdf) (PubMed)
33. Garbuzenko D.V. [Non-invasive assessment of portal hypertension in patients with liver cirrhosis]. Poliklinika 2015; (2): 33-39 (in Russian) (pdf)
34. Garbuzenko D.V. Contemporary concepts of the medical therapy of portal hypertension under liver cirrhosis. World J. Gastroenterol. 2015; 21 (20): 6117-6126 (pdf) (PubMed)
35. Garbuzenko D.V. Treatment of acute esophageal variceal bleeding in cirrhotic patients. Abdomen 2015; 2: e958  (pdf)
36. Garbuzenko D.V., Bordunovskii V.N. The Effect of Laser Revascularization of the Liver on Portal Hemodynamics in Cirrhotic Patients: Preliminary Study. Gastroenterol Hepatol Open Access 2015; 2 (6): 00060 (pdf)
37. Garbuzenko D.V. Current approaches to the management of patients with liver cirrhosis who have acute esophageal variceal bleeding. Curr Med Res Opin. 2016; 32 (3): 467-475 (pdf) (PubMed)
38. Garbuzenko D.V. [Aspects of pathogenetic pharmacotherapy for portal hypertension in liver cirrhosis]. Ter. Arkh. 2016; 88 (2): 101-108 (in Russian) (pdf) (PubMed)
39. Garbuzenko D.V., Arefyev N.O., Belov D.V. Mechanisms of adaptation of the hepatic vasculature to the deteriorating conditions of blood circulation in liver cirrhosis. World J. Hepatol. 2016; 8 (16): 665-672 (pdf) (PubMed)
40. Ivashkin V.T., Mayevskaya M.V., Pavlov Ch.S., Fedosyina Ye.A., Bessonova Ye.N.,  Pirogova I.Yu., Garbuzenko D.V. [Treatment of liver cirrhosis complications: Clinical guidelines of the Russian Scientific Liver Society and Russian gastroenterological association]. Ros. zhurn. gastrojenterol., gepatol., koloproktol. 2016; 26 (4): 71-102 (in Russian) (pdf)
41. Garbuzenko D.V. [The principles of primary prevention of bleeding from esophageal varices in patients with liver cirrhosis]. Klin. Med. (Mosk). 2016; 94 (7): 503-509 (in Russian) (pdf) (PubMed) 
42. Garbuzenko D.V., Arefyev N.O., Belov D.V. Restructuring of the vascular bed in response to hemodynamic disturbances in portal hypertension. World J. Hepatol. 2016; 8 (36): 1602-1609 (pdf) (PubMed)
43. Arefyev N.O., Garbuzenko D.V., Khasanov L.R. Choosing an Optimal Suture Material for Prehepatic Portal Hypertension Modeling. Int. J. Clin. Exp. Med. Sci. 2016; 2 (6): 117-121 (pdf) 
44. Arefyev N.O., Garbuzenko D.V., Emelyanov I.V., Khasanov L.R., Mineeva L.V. Changes in the microvasculature of small bowel mesentery in rats with prehepatic portal Hypertension: the preliminary study in vivo. Abdomen 2017; 4: e1580 (pdf)
45. Garbuzenko D.V. [The principles of management of patients with liver cirrhosis comlicated by ascites]. Klin. Med. (Mosk). 2017; 95 (9): 789-796 (in Russian) (pdf) 
46. Garbuzenko D.V., Arefyev N.O. Hepatic hydrothorax: An update and review of the literature. World J. Hepatol. 2017; 9 (31): 1197-1204 (pdf) (PubMed)
47. Arefyev N.O., Garbuzenko D.V., Kazachkov E.L., Bordunovskii V.N. [Portal hypertension associated angiogenesis assay in experimental studies (literature review)]. Ural. Med. Zhurn. 2018; (2): 16-23 (in Russian) (pdf)
48. Arefyev N.O., Garbuzenko D.V., Kazachkov E.L. Modern Methods for Studying Portal Hypertension Associated Angiogenesis in Experimental Research. Eur. Med. J. 2018; 3 (2): 90-99 (pdf)
49. Garbuzenko D.V., Belov D.V., Arefyev N.O. A rare case of internal small intestinal strangulation. General Surgery: Open Access. 2018; 1 (1): 3-4 (pdf)
50. Garbuzenko D.V., Arefyev N.O., Kazachkov E.L. Antiangiogenic therapy for portal hypertension in liver cirrhosis: Current progress and perspectives. World J Gastroenterol. 2018; 24 (33): 3738-3748 (pdf) (PubMed) 
51. Belov D.V., Garbuzenko D.V., Fokin A.A., Milievskaya E.B. [Risk factors of abdominal complications after coronary artery bypass grafting]. Byulleten' NTSSSKH im. A.N. Bakuleva RAMN «Serdechno-sosudistyye zabolevaniya». 2018; 19 (6): 794-799 (in Russian) (pdf)
52. Garbuzenko D.V. [Hydrothorax in liver disease: pathogenesis, diagnosis, treatment]. Klin. Med. (Mosk). 2018; 96 (7): 604-611 (in Russian) (pdf)
53. Garbuzenko D.V.,  Belov D.V., Arefyev N.O. A rare complication of cardiac surgery: Ogilvie syndrome. J Postgrad Med. 2019; 65 (1): 56-57 (pdf) (PubMed)
54. Belov D.V., Garbuzenko D.V., Milievskaya E.B., Bordunovskiy V.N. [Early abdominal complications after coronary artery bypass surgery with cardiopulmonary bypass: diagnosis and treatment]. Byulleten' NTSSSKH im. A.N. Bakuleva RAMN «Serdechno-sosudistyye zabolevaniya». 2019; 20 (4): 305-312 (in Russian) (pdf) 
55. Garbuzenko D.V., Arefyev N.O., Kazachkov E.L. Angiogenesis and Portal Hypertension: An Update. In: Anti-Angiogenesis Drug Discovery and Development. Vol. 4. Ed. Atta-ur-Rahman and M. Iqbal Choudhary. Sharjah, UAE: Bentham Science Publishers; 2019. p. 162-218 (pdf) 
56. Belov D.V., Garbuzenko D.V., Fokin A.A., Naymushina Yu.V., Milievskaya E.B., Lukin O.P., Peshikov O.V. [А prognostic scale for the prediction of early abdominal copmplications after coronary artery bypass surgery with cardiopulmonary bypass]. Russian Journal of Thoracic and Cardiovascular Surgery. 2019; 61 (3): 190–196 (in Russian) (pdf)
57. Garbuzenko D.V., Arefyev N.O. Current approaches to the management of patients with cirrhotic ascites. World J Gastroenterol. 2019; 25 (28): 3738-3752 (pdf) (PubMed)
58. Garbuzenko D.V., Belov D.V., Fokin A.A., Milievskaya E.B. [Acute pancreatitis after cardiac surgery with cardiopulmonary bypass]. Russian Journal of Thoracic and Cardiovascular Surgery. 2019; 61 (5): 415-422 (in Russian) (pdf)
59. Belov D.V., Garbuzenko D.V., Lukin O.P., Anufrieva S.S. [Role of laboratory methods in integrated diagnostics of acute mesenterial ischemia]. Medical Journal of the Russian Federation. 2019; 25 (5-6): 316-323 (in Russian) (pdf)
60. Belov D.V., Moskalev V.I., Garbuzenko D.V., Arefyev N.O. Left atrial appendage aneurysm: A case report. World J. Clin. Cases. 2020; 8 (19): 4443-4449 (pdf) (PubMed)
61. Belov D.V., Garbuzenko D.V., Abramovskikh K.A., Arefyev N.O. Risk score for predicting abdominal complications after coronary artery bypass grafting. World J. Cardiol. 2020; 12 (10): 492-500 (pdf) (PubMed)
62. Garbuzenko D.V., Arefyev N.O. Primary prevention of bleeding from esophageal varices in patients with liver cirrhosis: An update and review of the literature. J. Evid. Based Med. 2020; 13 (4): 313-324 (pdf) (PubMed)
63. Belov D.V., Garbuzenko D.V., Naymushina Yu.V., Lukin O.P., Milievskaya E.B., Leontiev S.N., Mezentsev V.I. [Prognostic scale for the prediction of early abdominal complications after correction of heart diseases with cardiopulmonary bypass]. Russian Journal of Thoracic and Cardiovascular Surgery. 2020; 5 (62): 426-431 (in Russian) (pdf)
64. Belov D.V., Garbuzenko D.V., Lukin O.P., Anufrieva S.S. [Heyde’s syndrome as a rare cause of gastrointestinal bleeding in aortic stenosis patients]. Cardiovascular Therapy and Prevention. 2021; 20 (1): 59-64 (in Russian) (pdf)
65. Belov D.V., Garbuzenko D.V., Anufrieva S.S. [A rare case of gerniation and incarceration of the gallbladder]. Khirurgiia (Mosk). 2021; (10): 110-112. (in Russian) (pdf) (PubMed)
66. Garbuzenko D.V. [The role of antiviral therapy in the management of patients with liver cirrhosis associated with chronic HBV and HCV infection]. Problems of Virology. 2021; 66 (5): 331-339. (in Russian) (pdf) (PubMed)
67. Garbuzenko D.V., Belov D.V. [Non-alcoholic fatty liver disease as an independent factor of cardiometabolic risk of cardiovascular diseases]. Experimental and Clinical Gastroenterology. 2021; 194 (10): 22–34. (in Russian) (pdf)
68. Belov D.V., Garbuzenko D.V., Andrievskikh S.I., Anufrieva S.S. [Aorto-digestive fistula: a rare cause of gastrointestinal bleeding]. Circulation Pathology and Cardiac Surgery. 2021; 25 (4): 23-29. (in Russian) (pdf)
69. Garbuzenko D.V. [Drug Therapy for Non-Alcoholic Steatohepatitis-Induced Liver Fibrosis]. Ros. zhurn. gastrojenterol., gepatol., koloproktol. 2021; 31 (5): 16-24. (in Russian) (pdf)
70. Garbuzenko D.V. [Non-invasive diagnosis of liver fibrosis associated with nonalcoholic steatohepatitis]. Russian Journal of Evidence-based Gastroenterology. 2021; 10 (4): 75–81. (in Russian) (pdf)
71. Garbuzenko D.V. [Diagnostic and risk stratification aspects of liver fibrosis progression in chronic hepatitis B and C viral infection]. Medical Journal of the Russian Federation. 2021; 27 (4): 373-384. (in Russian) (pdf)
72. Garbuzenko D.V. [Molecular stimuli of fibrogenic activation in hepatic stellate cells]. Pathological Physiology and Experimental Therapy, Russian Journal. 2022; 66 (1): 112–119. (in Russian) (pdf)
73. Garbuzenko D.V. Pathophysiological mechanisms of hepatic stellate cells activation in liver fibrosis. World J. Clin. Cases. 2022; 10 (12): 3662-3676. (pdf) (PubMed)
74. Garbuzenko D.V. [Mechanisms and Clinical Significance of Hepatic Fibrogenesis in Iron Overload]. Doctor.Ru. 2022; 21 (2): 23–29. (in Russian) (pdf)
75. Garbuzenko D.V. [Principles of diagnosis and treatment of alcohol-induced liver fibrosis]. Meditsinskiy Sovet. 2022; 16 (7): 104–114. (in Russian) (pdf)
76. Belov D.V., Naimushina Yu.V., Fokin A.A., Garbuzenko D.V., Leontiev S.N., Mezentsev V.I., Tabashnikova S.V., Semagin A.A. [The role of transesophageal echocardiography in gastrointestinal bleeding]. Kardiologiya i Serdechno-Sosudistaya Khirurgiya. 2022; 15 (3): 270‑276. (in Russian) (pdf)
77. Garbuzenko D.V. Pathophysiological mechanisms of cardiovascular disorders in non-alcoholic fatty liver disease. Gastroenterol. Hepatol. Bed Bench. 2022; 15 (3): 194-203. (pdf) (PubMed)
78. Garbuzenko D.V. Pathophysiological Prerequisites and Therapeutic Potential of Fecal Microbiota Transplantation in Severe Alcoholic Hepatitis. The Russian Archives of Internal Medicine. 2022; 12 (5): 352-362. (pdf)
79. Garbuzenko D.V. Current strategies for targeted therapy of liver fibrosis. Bulletin of Siberian Medicine. 2022; 21 (3): 154–165. (pdf)
80. Garbuzenko D.V., Belov D.V., Kosharnova A.L., Anufrieva S.S., Danko N.A. [Gallbladder herniation as a Rare Complication of Abdominal Drainage]. Novosti Khirurgii. 2022; 30 (3): 317-321. (in Russian) (pdf)
81. Garbuzenko D.V. [Gut microbiota modulation in acute decompensation of liver cirrhosis: theory and therapeutic potential]. Russian Journal of Evidence-based Gastroenterology. 2022; 11 (4): 65–76. (in Russian) (pdf)
82. Garbuzenko D.V., Belov D.V. Herniation and incarceration of the gallbladder through the abdominal drain site: A case report. Int. J. Abdom. Wall Hernia Surg. 2023; 6 (1): 53-55. (pdf)
83. Garbuzenko D.V. Therapeutic possibilities of gut microbiota modulation in acute decompensation of liver cirrhosis. World J. Hepatol. 2023; 15 (4): 525-537. (pdf) (PubMed)
84. Garbuzenko D.V. Contemporary concepts of prevention and management of gastroesophageal variceal bleeding in liver cirrhosis patients. World J. Hepatol. 2024; 16 (2): 126-134. (pdf) (PubMed)
85. Garbuzenko D.V. Mechanisms of epigenetic regulation in the fibrogenic activation of hepatic stellate cells in non-alcoholic fatty liver disease. Gene Expr. 2024; 23 (1): 31–43. (pdf) (PubMed)
86. Garbuzenko D.V. Liver fibrosis as an independent cardiovascular risk factor in non-alcoholic fatty liver disease. J. Transl. Gastroenterol. 2024; 2 (1): 21–29. (pdf)